Ankilozlovchi spondiloartritda IL-17 ning kasallik kechishidagi axamiyati

Please use this identifier to cite or link to this item: http://repo.tma.uz/xmlui/handle/1/360

Full metadata record

DC Field	Value	Language
dc.contributor.author	Axmedov X.S., Raximov S.S.	-
dc.date.accessioned	2024-12-16T18:45:53Z	-
dc.date.available	2024-12-16T18:45:53Z	-
dc.date.issued	2024	-
dc.identifier.citation	Toshkent	en_US
dc.identifier.issn	2181-7812	-
dc.identifier.uri	http://repo.tma.uz/xmlui/handle/1/360	-
dc.description.abstract	ankilozan spondilitda IL-17 zardobining kasallik faolligi parametrlari bilan bog’liqligini o’rgan- ish. Material va usullar: tadqiqotga ASAS 2023 mezon- lari asosida Toshkent tibbiyot akademiyasida ankilozan spondilit tashxisi qo‘yilgan o‘zbek millatiga mansub 40 nafar bemor ishtirok etdi. Bemorlarning o’rtacha yoshi 53,58±9,28 yosh, tana massasi indeksi 24,36±3,23 kg/m . Natijalar: CRO va IL-17 ning o’rtacha qiymatlari mos rav- ishda 0,3 (0,10-5,70) mg / dL va 9,30 (7,70-13,60) pg/dL edi. ASDAS-CRO tizimiga ko’ra, bemorlarda kasallik faolli- gi yuqori (62,5%), o’rtacha (35%) va faol emas (2,5%). IL- 17 darajalari AS bilan og’rigan bemorlarda kasallik faol- ligi bilan chambarchas bog’liq edi. Xulosa: spearmanning daraja testi IL-17 darajalari va ASDAS-CRO ballari o’rtasi- dagi munosabatni tahlil qilish uchun ishlatilishi mumkin.	en_US
dc.language.iso	en	en_US
dc.relation.ispartofseries	UO'K;616.711-002.72-007.274-085	-
dc.subject	ankilozlovchi spondiloartrit. IL-17, AS- DAS, BASDAI, Shober sinamasi.	en_US
dc.title	Ankilozlovchi spondiloartritda IL-17 ning kasallik kechishidagi axamiyati	en_US
dc.type	Article	en_US
Appears in Collections:	Articles

Files in This Item:

File	Description	Size	Format
Axmedov X.S., Raximov S.S..pdf	Ankilozlovchi spondiloartritda IL-17 ning kasallik kechishidagi axamiyati	750.22 kB	Adobe PDF	View/Open

DSpace JSPUI